abstract |
The invention relates to a combination comprising an Erb-B and VEGF receptor inhibitor; and one or more pharmaceutically active agents; pharmaceutical compositions comprising the combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising the combination. |